Total Payments
$203,317
2024 Payments
$13,849
Companies
27
Transactions
224
Medicare Patients
1,286
Medicare Billing
$282,899
Payment Breakdown by Category
Other$140,671 (69.2%)
Travel$30,117 (14.8%)
Consulting$24,814 (12.2%)
Food & Beverage$6,773 (3.3%)
Education$941.95 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $138,856 | 48 | 68.3% |
| Travel and Lodging | $30,117 | 43 | 14.8% |
| Consulting Fee | $24,814 | 11 | 12.2% |
| Food and Beverage | $6,773 | 103 | 3.3% |
| Honoraria | $1,250 | 1 | 0.6% |
| Education | $941.95 | 17 | 0.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $565.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $69,847 | 59 | $0 (2021) |
| BeiGene USA, Inc. | $48,543 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29,636 | 20 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $23,808 | 22 | $0 (2023) |
| GENZYME CORPORATION | $21,031 | 12 | $0 (2023) |
| Janssen Biotech, Inc. | $3,075 | 13 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $2,037 | 6 | $0 (2023) |
| Kite Pharma, Inc. | $1,926 | 3 | $0 (2021) |
| Epizyme, Inc., | $1,262 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $262.17 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,849 | 14 | BeiGene USA, Inc. ($13,680) |
| 2023 | $32,585 | 29 | BeiGene USA, Inc. ($16,532) |
| 2022 | $36,234 | 29 | E.R. Squibb & Sons, L.L.C. ($23,648) |
| 2021 | $18,235 | 18 | BeiGene USA, Inc. ($8,235) |
| 2020 | $3,642 | 8 | BeiGene USA, Inc. ($2,844) |
| 2019 | $66,712 | 67 | Celgene Corporation ($39,608) |
| 2018 | $12,116 | 24 | Celgene Corporation ($7,836) |
| 2017 | $19,944 | 35 | Celgene Corporation ($18,049) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Oncology | ||||||
| 11/21/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $779.51 | General |
| Category: Oncology | ||||||
| 11/21/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: Oncology | ||||||
| 07/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Oncology | ||||||
| 07/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
| 02/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,950.00 | General |
| Category: Oncology | ||||||
| 02/08/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | Cash or cash equivalent | $171.08 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $168.73 | General |
| Category: HEMATOLOGY | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $407.80 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $315.27 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Oncology | ||||||
| 10/25/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,494.00 | General |
| Category: Oncology | ||||||
| 10/25/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Travel and Lodging | In-kind items and services | $640.12 | General |
| Category: Oncology | ||||||
| 10/25/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Oncology | ||||||
| 09/20/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Oncology | ||||||
| 09/20/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $1,396.06 | General |
| Category: Oncology | ||||||
| 09/20/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $104.00 | General |
| Category: Oncology | ||||||
| 06/30/2023 | BeiGene USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| 06/21/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,932.00 | General |
| Category: Oncology | ||||||
| 06/21/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
| 06/14/2023 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $116.99 | General |
| Category: Hematology | ||||||
| 06/09/2023 | SANOFI-AVENTIS U.S. LLC | ELITEK (Biological) | Education | In-kind items and services | $85.95 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 273 | 636 | $272,449 | $72,474 |
| 2022 | 3 | 304 | 692 | $302,377 | $77,706 |
| 2021 | 4 | 303 | 650 | $275,505 | $74,950 |
| 2020 | 6 | 406 | 824 | $230,044 | $57,769 |
Total Patients
1,286
Total Services
2,802
Medicare Billing
$282,899
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 413 | $173,873 | $46,343 | 26.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 182 | $72,254 | $20,163 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $26,322 | $5,968 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 407 | $171,347 | $46,126 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 212 | $84,164 | $20,304 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $46,866 | $11,276 | 24.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 167 | 421 | $177,241 | $50,367 | 28.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 68 | 68 | $43,656 | $10,705 | 24.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 98 | $38,624 | $9,601 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 63 | $15,984 | $4,276 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 168 | 443 | $177,365 | $43,779 | 24.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 47 | 47 | $29,400 | $7,198 | 24.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 37 | $14,040 | $3,635 | 25.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 20 | $5,314 | $1,262 | 23.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 25 | 29 | $1,445 | $1,160 | 80.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 132 | 248 | $2,480 | $735.42 | 29.7% |
About Dr. Tauseef Ahmed, M.D
Dr. Tauseef Ahmed, M.D is a Hematology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093778458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tauseef Ahmed, M.D has received a total of $203,317 in payments from pharmaceutical and medical device companies, with $13,849 received in 2024. These payments were reported across 224 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,856).
As a Medicare-enrolled provider, Ahmed has provided services to 1,286 Medicare beneficiaries, totaling 2,802 services with total Medicare billing of $282,899. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Bronx, NY
- Active Since 04/07/2006
- Last Updated 04/25/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1093778458
Products in Payments
- Revlimid (Drug) $57,329
- BRUKINSA (Drug) $47,718
- Pomalyst (Drug) $32,433
- NINLARO (Drug) $29,388
- SARCLISA (Biological) $20,913
- KYMRIAH (Biological) $1,965
- Tecartus (Drug) $1,700
- DARZALEX (Biological) $1,592
- IMBRUVICA (Drug) $1,469
- TAZVERIK (Drug) $1,262
- Imbruvica (Drug) $250.00
- XARELTO (Drug) $249.10
- Yescarta (Drug) $226.25
- MONOFERRIC (Drug) $168.73
- VELCADE (Drug) $148.73
- Aliqopa (Drug) $125.00
- DEFITELIO (Drug) $124.74
- Rubraca (Drug) $118.74
- LIBTAYO (Drug) $117.92
- Blincyto (Biological) $117.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Bronx
Dr. Lucia Wolgast, M.d, M.D
Hematology — Payments: $23,003
Hematology $23,003
Ellen Friedman, Md, MD
Hematology — Payments: $21,507
Hematology $21,507
Henny Billett, Md, MD
Hematology — Payments: $12,556
Hematology $12,556
Zwi Schreiber, Md, MD
Hematology — Payments: $3,053
Hematology $3,053
Michael Stemerman, Md, MD
Hematology — Payments: $844.25
Hematology $844.25
Dr. Karenza Alexis, Md, MD
Hematology — Payments: $125.48
Hematology $125.48